Efficacy data for India's own coronavirus vaccine could boost its public acceptance

Any boost to the vaccine's acceptance in India, which on Thursday reported a new COVID-19 cases at their highest in five weeks, could also brighten its export prospects. Bharat Biotech said 40 countries were interested in COVAXIN.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3efopzc
via IFTTT